SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-21-008446
Filing Date
2021-04-09
Accepted
2021-04-09 17:23:13
Documents
16
Period of Report
2021-04-09

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 17616
2 ex99-1.htm EX-99.1 1089308
3 ex99-2.htm EX-99.2 3485
4 ex99-1_001.jpg GRAPHIC 8686
5 ex99-1_002.jpg GRAPHIC 4705
6 ex99-1_003.jpg GRAPHIC 4086
7 ex99-1_004.jpg GRAPHIC 62822
8 exb99-1_006.jpg GRAPHIC 8877
9 ex99-2_001.jpg GRAPHIC 328497
10 ex99-2_002.jpg GRAPHIC 198247
11 ex99-2_003.jpg GRAPHIC 759531
12 ex99-2_004.jpg GRAPHIC 242861
13 sce_001.jpg GRAPHIC 185376
14 sce_002.jpg GRAPHIC 117819
15 sce_003.jpg GRAPHIC 102974
16 sce_004.jpg GRAPHIC 83489
  Complete submission text file 0001493152-21-008446.txt   4015666
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 21818624
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences